We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement
Analytical Cannabis Logo
×

Home > News > Testing

Canadian Cannabis Market in Need of Standardization, Rigorous Testing

Published: May 04, 2018   

Complete the form below and we will email you a PDF version of "Canadian Cannabis Market in Need of Standardization, Rigorous Testing"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Analytical Cannabis?

Analytical Cannabis Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Canadian Cannabis Market in Need of Standardization, Rigorous Testing

Delivra has announced the publication of their analytical evaluation of a variety of third-party over-the-counter hemp consumer products for tetrahydrocannabinol (THC) and cannabidiol (CBD) content to further develop its internal expertise and evaluate the consumer landscape.


The publication conducted out of Delivra's research lab in Charlottetown, PEI and partially funded by Skills-PEI and by the Atlantic Canada Opportunities Agency, concluded that most third-party consumer products met the federal guidelines on THC content. However, the levels of CBD were higher than THC in multiple products and reflects the lack of federally mandated CBD testing of hemp-based finished products. As a tool, the testing method is amenable to a variety of consumer products indicating its general applicability towards cannabis oils and more complex materials like creams and edibles. Delivra is well positioned to be a preferred company of choice to provide the standardization of testing for the cannabis industry. These results have now been published in the respected peer-reviewed scientific journal, PLOS ONE, under the title, "A reliable and validated LC-MS/MS method for the simultaneous quantification of 4 cannabinoids in 40 consumer products". 


"This data underscores the variety of analytical expertise Delivra has developed in response to the intended legalization of cannabis-based products in Canada and is aligned with several active agreements between Delivra and third-party companies requesting our analytical and formulary expertise. Combining Delivra's unique knowledge of delivery systems with core analytical expertise prepares our company for further future opportunities in cannabis product development with a focus on safety and consistency," said Dr. Joseph Gabriele, CEO of Delivra.


This article has been republished from materials provided by Delivra. Note: material may have been edited for length and content. For further information, please contact the cited source.

 

Like what you just read? You can find similar content on the topic tag shown below.

Testing

Stay connected with the latest news in cannabis extraction, science and testing

Get the latest news with the FREE weekly Analytical Cannabis newsletter

 
Advertisement